Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Stability of Methimazole in Poloxamer Lecithin Organogel to Determine Beyond-Use Date

Author(s):  Pignato Alyssa, Pankaskie Marvin, Birnie Christine

Issue:  Nov/Dec 2010 - Volume 14, Number 6
View All Articles in Issue

Page(s):  522-525

Stability of Methimazole in Poloxamer Lecithin Organogel to Determine Beyond-Use Date Page 1
Stability of Methimazole in Poloxamer Lecithin Organogel to Determine Beyond-Use Date Page 2
Stability of Methimazole in Poloxamer Lecithin Organogel to Determine Beyond-Use Date Page 3
Stability of Methimazole in Poloxamer Lecithin Organogel to Determine Beyond-Use Date Page 4

Download in electronic PDF format for $75

Abstract:  The purpose of this stability study was to determine the beyond-use date of the active ingredient methimazole extemporaneously prepared for transdermal absorption to treat feline hyperthyroidism. The methimazole was prepared in poloxamer lecithin organogel and subjected to a three-month stability study. It was determined that under room temperature conditions (25°C ± 2°/60% RH ± 5%) the methimazole concentration remained above 90% after 62 days. An accelerated condition of 35°C and refrigerated condition of 5°C were also employed to see how temperature affected the stability of the drug. Under all three conditions the methimazole concentration dropped below 90% after day 62. It was observed that the refrigerated conditions appeared to be least stable both physically and chemically. A control sample was also prepared, stored, and packaged similarly to the sample preparations. As a result, the beyond-use date was determined to be 60 days at room temperature. The drug preparation should not be stored in a refrigerated condition.

Related Keywords: methimazole, topical preparation, transdermal administration, feline, cat, hyperthyroidism, stability, storage conditions, temperature, formulation

Related Categories: FORMULATIONS, PEER-REVIEWED, STABILITIES, COMPATIBILITIES, VETERINARY, DOSAGE FORMS/DRUG CARRIERS, STORAGE

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Stability of Methimazole in Poloxamer Lecithin Organogel to Determine Beyond-Use Date
Pignato Alyssa
, Pankaskie Marvin, Birnie Christine
Nov/Dec 2010
Pg. 522-525

Veterinary Transdermal Medications: A to Z
Davidson Gigi S
Mar/Apr 2003
Pg. 106-113

Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel
Woodall Rachel
, Arnold John J, McKay Doug, Abill C Scott
May/Jun 2013
Pg. 247-253

Five Compounds for Treating Diabetes-Related Conditions
Meece Jerry
May/Jun 2003
Pg. 170-174

Beyond-use Date of Trimix: A Reproducible Stability Study Using Bracketing Design
Patel Gopesh
, Davis Countaney, Liu Yi, Ip Kendice, Debideen Krystal E, Anderson Stephanie, Byrne Robert, Herr Dylan, Rhoads Melissa Merrell, Caputo Ross, Banov Daniel, Bassani August S
Jan/Feb 2021
Pg. 73-81

Evaluation of the Stability of Fluoxetine in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date
Peacock Gina F
, Sauvageot Jurgita
May/Jun 2014
Pg. 253-255

Methimazole 5 mg/0.1 mL in Pluronic Lecithin Organogel Gel, Veterinary
Allen Loyd V Jr
Jan/Feb 2019
Pg. 56

Basics of Sterile Compounding: Criteria for Determining Beyond-use Dating
Martin Matt
Jul/Aug 2018
Pg. 303-312

Evaluation of the Stability of Promethazine Hydrochloride in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date
Peacock Gina F
, Sauvageot Jurgita
Jul/Aug 2014
Pg. 345-347

Evaluation of the Stability of Ketoprofen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date
Peacock Gina F
, Sauvageot Jurgita, Addo Richard T
Jul/Aug 2014
Pg. 348-350

Transdermal Methimazole in the Treatment of 16 Cats with Hyperthyroidism
Wingate Gary
Sep/Oct 2002
Pg. 344-345

The Release and Transdermal Penetration of Baclofen Formulated in a Poloxamer Lecithin Organogel
Arnold John J
, Asbill Scott
Nov/Dec 2009
Pg. 569-571

Evaluating Transdermal Medication Forms for Veterinary Patients, Part 3: Methimazole
Davidson Gigi S
Jul/Aug 2001
Pg. 282-283

Basics of Compounding: Considerations for Implementing USP Chapter <797> -- Sterile Preparations, Part 19: Storage and Beyond-Use Dating, Maintaining Sterility, Purity, and Stability of Dispensed and Distributed Compounded Sterile Preparations
Okeke Claudia C
, Allen Loyd V Jr
May/Jun 2010
Pg. 232-238

Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery
Boddu Sai HS
, Bonam Sindhu Prabha, Wei Yangjie, Alexander Kenneth
May/Jun 2014
Pg. 256-261

Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs
Gorman Gregory
, Sokom Simara, Coward Lori, Arnold John J
Mar/Apr 2017
Pg. 164-170

Beyond-use Date: Establishment and Maintenance
Osteen Richard
Nov/Dec 2012
Pg. 471-474

Quality-Control Analytical Methods: Overview of Beyond-Use Dating for Compounded Sterile Preparations
Trissel Lawrence A
Nov/Dec 2008
Pg. 524-528

Standards of Practice, Professional Judgment, and Scientific Evidence to Establish and Extend a Beyond-Use Date
Thomson Cassandra Marie
, Savji Taslim
Nov/Dec 2014
Pg. 456-460

Intravenous Admixture Preparation Considerations, Part 7: Stability Issues
Allen Loyd V Jr
Nov/Dec 2020
Pg. 473-478

Return to Top